0.3(top 100%)
impact factor
61(top 100%)
papers
33(top 100%)
citations
2(top 100%)
h-index
0.3(top 100%)
impact factor
87
all documents
43
doc citations
5(top 100%)
g-index

Top Articles

#TitleJournalYearCitations
1Update on the Pharmacotherapy of Heart Failure with Reduced Ejection FractionCardiovascular Prevention and Pharmacotherapy202012
2Recent Technology-Driven Advancements in Cardiovascular Disease Prevention in KoreaCardiovascular Prevention and Pharmacotherapy20193
3Methods for Evaluating the Accuracy of Diagnostic TestsCardiovascular Prevention and Pharmacotherapy20212
4Aspirin Has a Neutral Effect in Preventing Future Cardiovascular Events in Vasospastic AnginaCardiovascular Prevention and Pharmacotherapy20192
5Challenges and Future in Precision Cardiovascular MedicineCardiovascular Prevention and Pharmacotherapy20192
6Competing Risk Model in Survival AnalysisCardiovascular Prevention and Pharmacotherapy20202
7Geriatric Considerations in the Management of Elderly Patients with Cardiovascular DiseasesCardiovascular Prevention and Pharmacotherapy20211
8Tafamidis for Cardiac Transthyretin AmyloidosisCardiovascular Prevention and Pharmacotherapy20211
9Inflammation in Metabolic Diseases and Insulin ResistanceCardiovascular Prevention and Pharmacotherapy20211
10Logistic Regression and Least Absolute Shrinkage and Selection OperatorCardiovascular Prevention and Pharmacotherapy20201
11Effects of Low-Carbohydrate, High-Fat Diets on Weight Loss, Cardiovascular Health and MortalityCardiovascular Prevention and Pharmacotherapy20201
12Improving Causal Inference in Observational Studies: Propensity Score MatchingCardiovascular Prevention and Pharmacotherapy20191
13Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary InterventionCardiovascular Prevention and Pharmacotherapy20191
14Asian Cohort Studies on Cardiovascular Risk Factors in ChildhoodCardiovascular Prevention and Pharmacotherapy20191
15Body Weight Change and Cardiovascular Disease: Effect of Weight Gain, Weight Loss, and Weight CyclingCardiovascular Prevention and Pharmacotherapy20211
16Changes in Target Achievement Rates after Statin Prescription Changes at a Single University HospitalCardiovascular Prevention and Pharmacotherapy20201
17Pragmatic Clinical Trials for Real-World Evidence: Concept and ImplementationCardiovascular Prevention and Pharmacotherapy20201
18Shifting from Pharmacotherapy to Prevention of HypertensionCardiovascular Prevention and Pharmacotherapy20201
19Effects of physical activity on cardiovascular outcomes and mortality in Korean patients with diabetes: a nationwide population-based cohort studyCardiovascular Prevention and Pharmacotherapy20221
20Safety and efficacy of low-dose aspirin in patients with coronary artery spasm: long-term clinical follow-upCardiovascular Prevention and Pharmacotherapy20221
21Adverse effects of statin therapy and their treatmentCardiovascular Prevention and Pharmacotherapy20221
22Targets for rescue from fatty acid-induced lipotoxicity in pancreatic beta cellsCardiovascular Prevention and Pharmacotherapy20221
23Development of a predictive model for the side effects of liraglutideCardiovascular Prevention and Pharmacotherapy20221
24Blood pressure control in hypertensive disorders of pregnancyCardiovascular Prevention and Pharmacotherapy20221
25Changes in cardiovascular-related health behaviors during the COVID-19 pandemicCardiovascular Prevention and Pharmacotherapy20231
26Vasopressin Receptor Antagonist, Tolvaptan, for Treating Hyponatremia in Patients with Heart FailureCardiovascular Prevention and Pharmacotherapy20210
27Perioperative Management of Hypertensive PatientsCardiovascular Prevention and Pharmacotherapy00
28Perceptron: Basic Principles of Deep Neural NetworksCardiovascular Prevention and Pharmacotherapy00
29Diabetes and Heart FailureCardiovascular Prevention and Pharmacotherapy20210
30Characteristics of Patients with Vasospastic Angina in Korea: Data from a Large Cohort (VA-KOREA)Cardiovascular Prevention and Pharmacotherapy00
31Preterm Labor and Later Maternal Cardiovascular Disease in General Population: Doubtful Relationship with AtherosclerosisCardiovascular Prevention and Pharmacotherapy20190
32Welcome to the New JournalCardiovascular Prevention and PharmacotherapyCardiovascular Prevention and Pharmacotherapy20190
33CYP2C19 Polymorphisms and Smoking Status Affects Responsiveness to the Platelet P2Y12 Receptor Antagonist ClopidogrelCardiovascular Prevention and Pharmacotherapy20190
34Pregnancy at Late Maternal Age and Future Cardiovascular HealthCardiovascular Prevention and Pharmacotherapy20190
35CHA2DS2-VASc Score Is Correlated with Cardiac Performance in Chronic Atrial FibrillationCardiovascular Prevention and Pharmacotherapy20200
36Improving Causal Inference in Observational Studies: Interrupted Time Series DesignCardiovascular Prevention and Pharmacotherapy20200
37Basic Concepts of a Mendelian Randomization ApproachCardiovascular Prevention and Pharmacotherapy20200
38Paradigm Shift for the Treatment of Type 2 Diabetes Mellitus in Patients with Cardiovascular Disease: Cardiologist's PerspectiveCardiovascular Prevention and Pharmacotherapy20200
39Relationship between Retinal nerve Fiber Layer Defects and Coronary Artery Calcium Score in Patients at Risk for Cardiovascular DiseaseCardiovascular Prevention and Pharmacotherapy20210
40Development of a Predictive Model for Glycated Hemoglobin Values and Analysis of the Factors Affecting ItCardiovascular Prevention and Pharmacotherapy20210
41Dose Selection of Non-Vitamin K Antagonist Oral Anticoagulants in Korean Patients with Non-Valvular Atrial FibrillationCardiovascular Prevention and Pharmacotherapy20200
42Prevention of Type 2 DiabetesCardiovascular Prevention and Pharmacotherapy20200
43Causal Claims in Health Sciences and Medicine: a Difference-in-Differences MethodCardiovascular Prevention and Pharmacotherapy20200
44From Traditional Statistical Methods to Machine and Deep Learning for Prediction ModelsCardiovascular Prevention and Pharmacotherapy20200
45Barriers in Salt Reduction Strategies: Time to Acting for the FutureCardiovascular Prevention and Pharmacotherapy20200
46Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic AttackCardiovascular Prevention and Pharmacotherapy20210
47Diabetes in People with Disabilities: a Call for ActionCardiovascular Prevention and Pharmacotherapy20210
48Modeling of Changes in Creatine Kinase after HMG-CoA Reductase Inhibitor PrescriptionCardiovascular Prevention and Pharmacotherapy20210
49Association between Myocardial Infarction Location and In-Hospital Mortality in Iran: A Nationwide StudyCardiovascular Prevention and Pharmacotherapy20210
50Anti-inflammatory effects of colchicine on coronary artery diseaseCardiovascular Prevention and Pharmacotherapy20220